English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Background  The first International Society of Atopic Dermatitis ( ISAD ) global meeting dedicated to atopic dermatitis ( AD ) in Sub‐Saharan Africa ( SSA ) was held in Geneva, Switzerland in April 2019. A total of 30 participants were present at the meeting, including those from 17  SSA  countries, representatives of the World Health Organization ( WHO ), the International Foundation for Dermatology ( IFD ) (a committee of the International League of Dermatological Societies,  ILDS   www.ilds.org ), the Fondation pour la Dermatite Atopique, as well as specialists in telemedicine, artificial intelligence and therapeutic patient education ( TPE ).    Results   AD  is one of the most prevalent chronic inflammatory skin diseases in  SSA . Besides neglected tropical diseases ( NTD s) with a dermatological presentation,  AD  requires closer attention from the  WHO  and national Departments of Health.    Conclusions  A roadmap has been defined with top priorities such as access to essential medicines and devices for  AD  care, in particular emollients, better education of primary healthcare workers for adequate triage (e.g. better educational materials for skin diseases in pigmented skin generally and  AD  in particular, especially targeted to Africa), involvement of traditional healers and to a certain extent also patient education, bearing in mind the barriers to effective healthcare faced in  SSA  countries such as travel distances to health facilities, limited resources and the lack of dermatological expertise. In addition, several initiatives concerning  AD  research in  SSA  were discussed and should be implemented in close collaboration with the  WHO  and assessed at follow‐up meetings, in particular, at the next  ISAD  meeting in Seoul, South Korea and African Society of Dermatology and Venereology ( ASDV ) meeting in Nairobi, Kenya, both in 2020.

Position Statement on Atopic Dermatitis in Sub‐Saharan Africa: current status and roadmap